Xilio Therapeutics, Inc. (XLO)
8.50
+0.09
(+1.07%)
USD |
NASDAQ |
Apr 01, 16:00
8.50
0.00 (0.00%)
After-Hours: 19:40
Xilio Therapeutics Market Cap : 49.15M for April 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 587.70B |
| Merck & Co., Inc. | 298.71B |
| Pfizer Inc. | 161.95B |
| Verastem, Inc. | 486.17M |
| ACADIA Pharmaceuticals, Inc. | 3.808B |
Market Cap Related Metrics
| PS Ratio | 5.084 |
| Price to Book Value | 1.393 |
| Price | 8.50 |
| Earnings Yield | -38.26% |